News

Medical Dialogues4h
Thyroid Cancer Red Flag: FDA Adverse Reporting Data Analysis Shows Alerts on Semaglutide, Tirzepatide Use
Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...
Weight loss drugs could come with hefty price tags as FDA declares end of semaglutide shortage
The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...
Kentucky Today1d
Ashland doctor pleads guilty to receiving, selling unapproved semaglutide
An Ashland physician and owner of Lewis Family Care, Matthew Lewis, 44, has pleaded guilty at U.S. District Court in Ashland ...
News-Medical.Net on MSN10d
Semaglutide linked to higher risk of vision problems, FDA data analysis shows
Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...
Healthline10d
Compounded Semaglutide the Same as Ozempic?
Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...
The surprising role lizard venom played in inventing Ozempic — as FDA warns about fakes being sold
The Gila monster is a large, magnificent, and venomous desert-dwelling reptile found throughout the southwestern US and Mexico. A toxic bite from the Gila can cause searing pain, loss of consciousness ...
The GLP-1 drug shortage is over. What’s next for the compounders?
Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...
Kentucky doctor admits providing non-approved drug to weight-loss patients
A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...